# US 2024/0175878 A1 · Method for creating calibration curve and method for measuring amyloid ß-related peptide

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0175878 A1
- Document ID: US20240175878A1
- Status: Published application
- Kind: A1
- Application number: 18/285,134
- Filed: 2022-02-09
- Published: 2024-05-30
- Earliest claimed: 2021-04-05
- Assignees: Shimadzu Corporation
- Applicants: Shimadzu Corporation
- Inventors: Naoki KANEKO
- Web page: https://patentgrep.com/patent/US20240175878A1

## CPC

- C07K 17/02: Peptides being immobilised on, or in, an organic carrier
- G01N 33/6896: {Neurological disorders, e.g. Alzheimer's disease}
- C07K 16/18: against material from animals or humans
- G01N 27/62: by investigating the ionisation of gases, e.g. aerosols; by investigating electric discharges, e.g. emission of cathode
- G01N 33/54393: {Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding}
- G01N 33/6848: {Methods of protein analysis involving mass spectrometry}
- G01N 33/96: involving blood or serum control standard
- G01N 2333/4709: Amyloid plaque core protein
- G01N 2496/00: Reference solutions for assays of biological material
- G01N 2800/2821: Alzheimer
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Included is the steps of providing a plurality of standard solutions containing amyloid β-related peptide and a surfactant and having different concentrations of the amyloid β-related peptide; mixing a solution containing internal standard peptide with each of the plurality of standard solutions; performing immunoprecipitation and mass spectrometry on a plurality of calibration curve solutions; standardizing signal intensity (A) in the amyloid β-related peptide with the signal intensity (B) in the internal standard peptide for each of the plurality of calibration curve solutions; and calculating a regression equation of a calibration curve based on a plurality of normalized intensities and the concentration of the amyloid β-related peptide.

## Claims

### Claim 1

A method for creating a calibration curve for quantifying amyloid β-related peptide, the method comprising the steps of.
providing a plurality of standard solutions containing the amyloid β-related peptide and a surfactant and having different concentrations of the amyloid β-related peptide;
mixing a solution containing internal standard peptide with each of the plurality of standard solutions to obtain a plurality of calibration curve solutions,
performing immunoprecipitation and mass spectrometry on the plurality of calibration curve solutions to obtain signal intensity (A) in the amyloid β-related peptide and signal intensity (B) in the internal standard peptide for each of the plurality of calibration curve solutions;
standardizing the signal intensity (A) with the signal intensity (B) for each of the plurality of calibration curve solutions to obtain a plurality of normalized intensities; and
calculating a regression equation of a calibration curve based on the plurality of normalized intensities and the concentration of the amyloid β-related peptide corresponding to the plurality of normalized intensities.

### Claim 2 (depends on 1)

The creation method according to claim 1, wherein the surfactant is a nonionic surfactant.

### Claim 3 (depends on 1)

The creation method according to claim 1, wherein the amyloid β-related peptide is at least one selected from the group consisting of Aβ1-40, Aβ1-42, and APP669-711.

### Claim 4 (depends on 1)

The creation method according to claim 1, wherein the immunoprecipitation and the mass spectrometry includes:
a first bonding step of bringing the calibration curve solution into contact with a first carrier to obtain a first conjugate in which the amyloid β-related peptide is bonded to the first carrier;
a first washing step of washing the first conjugate;
a first elution step of bringing the first conjugate into contact with a first acidic solution to obtain a first eluate in which the amyloid β-related peptide is eluted in the first acidic solution;
a neutralization step of mixing the first eluate with a neutral buffer to obtain a purification solution;
a second bonding step of bringing the purification solution into contact with a second carrier to obtain a second conjugate in which the amyloid -related peptide is bonded to the second carrier;
a second washing step of washing the second conjugate;
a second elution step of bringing the second conjugate into contact with a second acidic solution to obtain a second eluate in which the amyloid β-related peptide is eluted in the second acidic solution; and
a detection step of detecting the amyloid β-related peptide in the second eluate by mass spectrometry.

### Claim 5 (depends on 1)

A method for measuring amyloid β-related peptide comprising quantifying amyloid β-related peptide in a measurement sample using a calibration curve obtained by the creation method according to claim 1.
